20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Sub-classes:METHODS FOR MODULATING REGULATORY T CELLS
#2PHARMACEUTICAL COMPOSITIONS FEATURING MIXTURES OF PEPTOIDS WITH AND WITHOUT TERMINAL ALIPHATIC MOIETIES
#3THERAPEUTIC PEPTIDES AND METHODS FOR TREATING AUTOIMMUNE RELATED DISEASE
#4ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#5Oral Film with Multiple Regions for Therapy of Periodontal and Dental Diseases or Disorders
#6NOVEL THERAPEUTICS FOR PARASITIC INFECTION
#7METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#8QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS
#9CHIMERIC PROTEIN COMPRISING AN ANTI-INFLUENZA VIRUS ANTIBODY MOIETY AND A MUCOADHESIVE PEPTIDE FRAGMENT FOR PREVENTING OR TREATING INFLUENZA INFECTIONS
#10GLYCOTARGETING THERAPEUTICS
#11PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION
#12CYCLIC PROSAPOSIN PEPTIDES AND USES THEREOF
#13A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE
#14COMPOSITIONS AND METHODS FOR TREATMENT
#15SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF
#16OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION
#17PEPTIDE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF SKIN AND MUCOUS MEMBRANE WOUNDS AND IN COSMETIC APPLICATIONS
#18IDENTIFICATION OF HIGHLY IMMUNOSUPRESIVE TREG POPULATION IN TUMOR MICROENVIRONMENTS
#19Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis
#20Polyhomoarginine (PHA) Polymers And Uses Thereof
#21NASAL DELIVERY OF APIGENIN AND LINEAR PEPTIDE INHIBITORS OF MITOCHONDRIAL FISSION
#22PHARMACEUTICAL COMPOSITIONS
#23COMPOSITIONS AND METHODS FOR TREATING DRUG ADDICTION
#24DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#25DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
#26T CELL EPITOPES ASSOCIATED WITH TYPE 1 DIABETES
#27LARAZOTIDE FORMULATIONS
#28METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#29PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#30MILK DERIVED EXOSOMES AND USES THEREOF
#31WOUND CARE DEVICE
#32METHODS FOR TREATING DISEASE AND REDUCING DRUG-INDUCED LIVER INJURY IN PATIENT POPULATIONS
#33PREPARATION METHOD OF LONG-ACTING SUSTAINED AND CONTROLLED RELEASE IMPLANT
#34SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#35PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#36PEPTIDE INHIBITOR AND USE THEREOF
#37TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#38METHODS AND COMPOSITIONS TO MODULATE RIOK2
#39ANTIHYPERTENSIVE PEPTIDE PROBIOTIC GOAT MILK POWDER AND PREPARATION METHOD THEREOF
#40SKELETON PROTECTION METHOD USING PEPTIDE
#41PEPTIDE EXHIBITING MUSCLE LOSS PREVENTION AND MUSCLE MASS PROMOTION ACTIVITIES, AND USE THEREOF
#42NOVEL ANTI-INFLAMMATORY PEPTIDE AND USE THEREOF
#43PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS
#44Methods For Treating Alzheimer's Disease or Dementia Using A Calcilytic And A Calcimimetic
#45POLYPEPTIDES HAVING ANTI-INFLAMMATORY EFFECTS AND USES THEREOF
#46NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS
#47PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE
#48PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#49CORONAVIRUS THERAPEUTICS AND TREATMENT METHODS
#50MICAFUNGIN COMPOSITIONS
#51MIXTURES AND FORMULATIONS COMPRISING AN ALKYL AMMONIUM EDTA SALT
#52COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE CONTAINING NOVEL COMPOUND
#53IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#54METHOD FOR TREATING OR PREVENTING ALOPECIA
#55STABLE COMPOSITIONS OF FOXY-5 HEXAPEPTIDE WITH HIGH SOLUBILITY
#56COLLAGEN-IMPREGNATED DEVICES AND METHODS FOR TREATMENT OF CANCER
#57NAP FOR SEX-SPECIFIC TREATMENT OF DISEASES
#58INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#59DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF
#60TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS
#61STABLE, READY-TO-ADMINISTER AQUEOUS FORMULATIONS OF DALBAVANCIN
#62ANTIFUNGAL AGENTS AND USES THEREOF
#63TYROSINE INHIBITORS WITH IMMUNOSUPPRESSIVE ACTIVITY IN HUMAN NEONATAL KERATINOCYTE PROGENITORS
#64METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION
#65PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#66METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#67METHODS OF TREATING CANCER BY INHIBITING BACTERIAL DNAK TO RESTORE ACTIVITIES OF ANTICANCER DRUGS
#68VESICLES AND USES THEREOF
#69NOVEL DAROBACTIN DERIVATIVES
#70COMPOSITIONS AND METHODS FOR TREATMENT
#71CASPASE-2 INHIBITOR COMPOUNDS
#72GENE THERAPY FOR TREATING NEURODEGENERATIVE DISEASES
#73COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)
#74BROAD-SPECTRUM PEPTOIDS FOR TREATMENT OR PREVENTION OF WOUND INFECTIONS, AND COMPOSITIONS AND METHODS OF USE THEREOF
#75PEPTOIDS FOR TREATING FILOVIRIDAE INFECTIONS
#76COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)
#77MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME
#78BROAD-SPECTRUM PEPTOIDS FOR ORAL AND DENTAL HYGIENE, AND COMPOSITIONS AND METHODS OF USE THEREOF
#79AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#80METHODS FOR REDUCING CD36 EXPRESSION
#81PEPTIDES AND METHODS OF USE THEREOF IN TREATING SKIN DISEASES
#82NOVEL COMPOSITION
#83ADMINISTRATION OF AN ANTICANCER PEPTIDE
#84POLYPEPTIDES HAVING ANTI-SENESCENT EFFECTS AND USES THEREOF
#85BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF
#86DISTINCT CD8+ T CELL PROGRAMMING IN THE TUMOR MICROENVIRONMENT CONTRIBUTES TO SEX BIAS IN CANCER
#87BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN
#88PHARMACEUTICAL COMPOSITION FOR MODULATING IMMUNE RESPONSE
#89COMPOSITIONS AND METHODS FOR TREATMENT OF BONE-RELATED DISEASE OR DISORDER
#90COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION
#91COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODAMAGE
#92Methods and Compositions for Use of a Chemokine Receptor Antagonist Peptide to Treat Addiction, Substance Abuse Disorders or Symptoms Thereof
#93Compositions and Methods of Treatment of Certain Vasculitis Syndromes
#94COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES
#95Compositions and Methods for Treating Neuropathy
#96BLOCK COPOLYMERS
#97EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS
#98SUSTAINED RELEASE PEPTIDE FORMULATIONS
#99PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#100CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#101ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#102METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#103COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS
#104METHOD FOR PREVENTING OR TREATING PARKINSON'S DISEASE
#105CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA
#106NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#107COMPOSITIONS AND METHODS FOR INHIBITING RHO KINASE
#108CHANNEL MODULATORS
#109VHH ANTIBODY
#110METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#111BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN
#112MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN
#113PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY AND USE THEREOF
#114ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE
#115IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES
#116METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA
#117INTRANASAL ADMINISTRATION
#118MODIFIED PEPTIDOMIMETICS AND METHODS OF USE
#119METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#120ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES
#121DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
#122SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#123COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LUNG INJURY
#124MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF
#125Methods and Compositions for Delivery of Biotin to Mitochondria
#126Application of Polypeptide in Preparation of Product for Preventing or Treating Skin Injury Diseases
#127BROAD-SPECTRUM ANTIVIRAL DRUGS
#128PROTECTION AGAINST ARTHROPOD PARASITES WITH PURINERGIC RECEPTOR (OPR) ANTAGONISTS
#129BIOORTHOGONAL COMPOSITIONS
#130SQUID-DERIVED PEPTIDES AND USES THEREOF
#131PHARMACEUTICAL USE
#132COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS
#133IMMUNITY-ENHANCING PEPTIDE ANALOGS AND USES THEREOF
#134COMBINATION OF OCTAPEPTIDE AND HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR TOPICAL APPLICATION
#135OCTAPEPTIDE FOR TOPICAL APPLICATION
#136PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#137POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF
#138Formulations and Methods for Treating Symptoms of Menopause
#139METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDACI) SUBSTANCES
#140OPTIMIZED SHORTENED PEPTIDE THAT BINDS TO ACETYLCHOLINE RECEPTOR, AND USE THEREOF
#141ENDOTHELIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OR PREVENTING MUSCLE FIBROSIS
#142METHODS FOR IMPROVING SKIN CONDITION, HAIR HEALTH, ANTI-INFLAMMATION ACTIVITY, CARDIOVASCULAR HEALTH, ANTI-OXIDATION ACTIVITY, ANTI-AGING ACTIVITY, AND/OR RELIEVING BODY FATIGUE BY USING YEAST POWDER RICH IN NICOTINAMIDE MONONUCLEOTIDE
#143PEPTIDE AND ITS USES
#144PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PAIN, COMPRISING GR82334 AS ACTIVE INGREDIENT
#145CEACAM BASED ANTIBACTERIAL AGENTS
#146METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS
#147NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF
#148METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
#149PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF
#150COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCER
#151USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION
#152METHODS OF TREATING PRADER-WILLI SYNDROME
#153COMPOSITIONS AND METHODS FOR TREATING MUCOSITIS
#154PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF
#155PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS
#156METHODS AND COMPOSITIONS FOR TREATING CANCERS AND OTHER PROLIFERATIVE DISORDERS
#157PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY, AND USE THEREOF
#158Protective Agent Against Endothelial Dysfunction
#159INHIBITION OF TUMOR NECROSIS FACTOR, PRO-INFLAMMATORY CYTOKINES AND OTHER INFLAMMATORY RESPONSE MEDIATORS
#160PEPTIDES AND METHODS FOR TREATING DISEASES
#161IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
#162OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
#163COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#164PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
#165COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
#166NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS
#167COMPOSITIONS AND METHOD FOR TREATING ACUTE RADIATION SYNDROME
#168FUNCTIONAL OUTCOMES AFTER SPINAL CORD INJURY
#169STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#170Polypeptides having anti-senescent effects and uses thereof
#171PEPTIDE HAVING OBESITY AND MUSCLE LOSS INHIBITORY ACTIVITIES, AND USE THEREOF
#172PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF
#173STABLE ANTI-CD79B IMMUNOCONJUGATE FORMULATIONS
#174BLOCK COPOLYMERS
#175TREATMENT
#176METHODS FOR TREATING SYMPTOMS OF DRY EYE DISEASE
#177COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INTESTINAL PARACELLULAR PERMEABILITY
#178MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY
#179COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION
#180METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#181The Use of Thiourea and Thiourea Derivatives As Potentiators of Antibacterial Activity of Peptoids
#182TOPICAL COMPOSITIONS
#183Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects
#184SILICONE POLYMER COMPOUND AND TRANSDERMAL DELIVERY SYSTEM COMPRISING SAME
#185Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists
#186ANTIVIRAL COMPOSITION COMPRISING A NUCLEOLIN-BINDING PEPTIDE
#187NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#188Immune checkpoint inhibitor combinations
#189PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF
#190VISTA AGONISTS AND RELATED COMPOSITIONS AND METHODS
#191METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#192PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION
#193COMBINATION THERAPY FOR TREATING CANCER
#194COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS
#195DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE
#196PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF
#197METHOD FOR TREATING OR PREVENTING NEOVASCULAR EYE DISEASE
#198ANTIMICROBIAL PEPTIDES
#199CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF
#200COMBINATION THERAPY WITH SEMAX AND CANNABIDIOL
#201Dry powder formulation of caveolin-1 peptides and methods of use thereof
#202RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#203TOPICAL AND PARENTERAL USE AND ADMINISTRATION OF SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS
#204METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE
#205ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#206Compositions and Methods for Treating Persistent Postsurgical Pain
#207METHODS FOR TREATING AMBLYOPIA
#208Method of treating diseases
#209Method of treating diseases
#210CANCER TREATMENT BY TARGETING PROTEINS OR INTERACTIONS OF EPHRINB-RGS3-KIF20A-SEPT7 AXIS
#211INHIBITORS AND USES THEREOF
#212alpha-SYNUCLEIN AGGREGATION INHIBITOR, PHARMACEUTICAL COMPOSITION FOR alpha-SYNUCLEIN DISEASE, AND USE THEREOF
#213ORAL PEPTIDE ANTAGONISTS OF MULTIPLE CHEMOKINE RECEPTORS FOR REVERSING LOSS OF SYNAPSES AND DENDRITIC SPINES
#214ANTI-OBESITY PEPTIDES AND USES THEREOF
#215METHOD FOR TREATING REFRACTORY BRAIN TUMOR
#216IL1RA DERIVED PEPTIDES FOR TREATMENT OF DIABETIC NEPHROPATHY
#217PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG
#218ETELCALCETIDE FORMULATIONS
#219COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
#220METHODS AND APPARATUS FOR GUIDING MEDICAL CARE BASED ON DETECTED GASTRIC FUNCTION
#221HEPTAPEPTIDE AMIDES FOR USE IN THE TREATMENT OF HMGB1-DEPENDENT DISEASES
#222POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT
#223ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION
#224ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT
#225PEPTIDES FOR THE TREATMENT OF CANCER
#226METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS
#227COMPOSITION FOR ANTI-FATIGUE COMPRISING GREEN TEA PEPTIDE COMPOSITION
#228Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis
#229ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#230LGG-DERIVED PEPTIDES AND METHODS OF USE THEREOF
#231PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES
#232BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE
#233COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY
#234CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN
#235TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME
#236Beta-Lactamase Inhibitors
#237DERMATOLOGICAL COMPOSTIONS AND USE THEREOF
#238ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#239COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE
#240COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS
#241TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
#242PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
#243COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN
#244CYCLIC PROSAPOSIN PEPTIDES AND USES THEREOF
#245PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6
#246TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#247A STABLE ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL COMBINATION FOR TREATMENT AND PREVENTION OF PSORIASIS
#248PHARMACEUTICAL COMPOSITIONS
#249TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE
#250PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS
#251DPEP-1 Binding Compositions and Methods of Use
#252BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY A COMBINATION OF BIOINFORMATICS TECHNIQUE AND CHEMICAL SYNTHESIS
#253APLNR Modulators and Uses Thereof
#254METHOD OF TREATING DISEASES
#255PEPTIDE THERAPEUTICS FOR INCREASING LUNG CELL VIABILITY
#256PEPTIDE FOR USE IN THE TREATMENT OR PREVENTION OF COVID-19
#257Compositions and methods of use for treatment or improvement of the condition and appearance of skin
#258Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#259SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#260METHODS AND COMPOSITIONS FOR TREATING CD44+ CANCERS
#261IMMUNOSTIMULATORY METHOD
#262ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#263CONJUGATES FOR IMMUNOTHERAPY
#264PEPTIDES FOR PREVENTING OR TREATING HEART AND BLOOD VESSEL DISEASES
#265PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION
#266USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS FOR TREATING TP53-MUTATED ACUTE MYELOID LEUKEMIA
#267ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
#268N-f-MLF DERIVATIVES THAT INHIBIT FORMYL PEPTIDE RECEPTORS FOR THE TREATMENT OF DISEASE
#269METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#270AUTOPHAGY-INHIBITING PEPTIDE AND ORGANIC ACID SALT THEREOF ADDRESSING ISSUES OF VASCULAR PERMEABILITY
#271Coronavirus Therapy
#272COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE
#273COMPOSITIONS AND METHODS FOR PREDICTING RISK OF MODERATE TO SEVERE COVID-19 DISEASE
#274USE OF PEPTIDES AS THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES
#275METHODS AND MATERIALS FOR TREATING CANCER
#276Glycan-Interacting Compounds and Methods of Use
#277COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES
#278WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE
#279Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same
#280COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER
#281COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION
#282PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF
#283TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS
#284MACROCYCLIC PEPTIDES
#285COMPOSITIONS AND METHODS RELATING TO ALOPECIA
#286MUSCULAR FUNCTION IMPROVING AGENT FOR SKELETAL MUSCLE OF WHICH FUNCTION IS DEGRADED DUE TO AGING
#287BACTERIAL-BINDING PEPTIDES FOR TREATMENT OF INFECTIOUS DISEASES AND RELATED INFLAMMATORY PROCESSES
#288INTRANASAL ADMINISTRATION
#289METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH ACTIVATION OF THE MAPK PATHWAY
#290SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#291Compositions and method for optimized peptide vaccines using residue optimization
#292COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME
#293TOPICAL COMPOSITION
#294NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#295SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE
#296Lipid conjugated peptide inhibitors of PICK1
#297IMPROVED WOUND CARE DEVICE
#298Compositions and methods for improving bruising and rejuvenating skin
#299PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS
#300Treatments for Gastrointestinal Disorders